Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myofibroma × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 379 Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Neoplasms, Plasma Cell 68 Recurrence 59 Lymphoma 52 Leukemia 49 Neoplasms 44 Vomiting 35 Immunoglobulin Light-chain Amyloidosis 33 Burkitt Lymphoma 33 Lymphoma, Mantle-Cell 30 Lymphoma, Large B-Cell, Diffuse 26 Nausea 25 Lymphoma, Non-Hodgkin 24 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hodgkin Disease 19 Prostatic Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Extranodal NK-T-Cell 15 Leukemia, Myeloid, Acute 15 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Amyloidosis 13 Smoldering Multiple Myeloma 12 Lymphoma, B-Cell, Marginal Zone 12 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large-Cell, Immunoblastic 9

Interventions

Uterine Myomectomy 3 Saline Solution 3 Misoprostol 3 Hysterectomy 3 dienogest 2 carbetocin 2 Tranexamic Acid 2 Tourniquets 2 Lidocaine 2 Hysteroscopy 2 Ascorbic Acid 2 remimazolam 1 relugolix 1 ramosetron 1 Vasopressins 1 Uterine Artery Embolization 1 Triptorelin Pamoate 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Observation 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02056717 2015-04-17

Use of Dexamethasone in Uterine Artery Embolization

Severance Hospital

Phase NA Completed

Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡